🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Long term update (median FU 91 mos) of HOVON-65/GMMG-HD4 study compares VAD to PAD. Clear evidence of benefit for those with renal dysfunction and -17. Also shows challenge with using OS in MM trials #ASH19RF #mmsm #ASH19

ICYMI: #Levofloxacin #prophylaxis in patients with newly diagnosed #myeloma—results from the phase 3 TEAMM study thelancet.com/journals/lanon…

MayoAZHemOncFellows see below from SV Rajkumar

1/16 Let's start off 2020 with some #Bacteremia myth💥!! Some questions answered here: Do fevers predict bacteremia? Can you predict when someone will have an ESBL bacteremia? I learned a lot preparing this review, I hope you do too #MedTwitter #IDTwitter #MedEd

Great Collaboration, thanks to all!Global GermCellCa Group: 51 patients with CS I NSGCT who experienced a relapse after adj BEP: ⭕️63% of relapses occurred during the first 2 years! ⭕️Late relapses as a predictor of poor outcome! doi.org/10.1200/JCO.19

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? buff.ly/2Q3WJB3 Blood Advances

Excellent paper on AML The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience onlinelibrary.wiley.com/doi/full/10.11…

The prospective clinical MSKCC NGS cohort is now >50,000 samples sequenced. Thanks to the hundreds of physicians, laboratory technicians, data scientists, nurses and support staff @sloan_kettering who have made this initiative possible. A few thoughts on what we have learned.